Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice.
about
GEMMs as preclinical models for testing pancreatic cancer therapiesMolecular Targeted Intervention for Pancreatic CancerStatins and pancreatic cancer.Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10)Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.Prospective analysis of association between statins and pancreatic cancer risk in the Women's Health Initiative.Pancreatic Cancer Chemoprevention Translational Workshop: Meeting ReportInfluence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer.Marketed drugs used for the management of hypercholesterolemia as anticancer armament.A screen for inducers of bHLH activity identifies pitavastatin as a regulator of p21, Rb phosphorylation and E2F target gene expression in pancreatic cancer.Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control StudyAtorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro.Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer.Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin
P2860
Q26781848-686E96D5-A2E2-4F13-B3D1-811ECE5D0DF6Q26798453-375C37FE-E02D-4A68-A29A-3E0E09B3B153Q33597969-5A6A87AC-DDEA-46CC-BEBC-DD8F876569F8Q37151656-ADAE3071-056F-4995-87F8-37092E37D971Q37617965-4CBE55B4-F9A8-43E2-BC33-665DE51126EFQ38726849-85E5B2A9-7736-4C7C-8421-1FC553D64BA0Q38831886-9C34F448-BFAB-4C62-ACE3-D5A3A8C05CE0Q40400445-8D10AAA0-364E-49BE-AD06-39346930EBD3Q41080847-F1F66C78-C3D4-4E7A-B559-4E2B3414EBCFQ41593086-CC35810D-DA3F-4A2D-8ECD-6F1BF130804CQ42376056-4BE75021-0D07-44C4-885E-E25E500E9706Q47193411-DD730A9B-5983-4179-87DD-12F5E4ABF317Q52688122-B05A5459-3DC7-46B0-B183-829A1604B2DBQ57176118-A6E8B286-1B5C-4914-B441-F6C51F9CD2AC
P2860
Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Atorvastatin inhibits pancreat ...... -LSL-Trp53R172H-Pdx1-Cre mice.
@ast
Atorvastatin inhibits pancreat ...... -LSL-Trp53R172H-Pdx1-Cre mice.
@en
type
label
Atorvastatin inhibits pancreat ...... -LSL-Trp53R172H-Pdx1-Cre mice.
@ast
Atorvastatin inhibits pancreat ...... -LSL-Trp53R172H-Pdx1-Cre mice.
@en
prefLabel
Atorvastatin inhibits pancreat ...... -LSL-Trp53R172H-Pdx1-Cre mice.
@ast
Atorvastatin inhibits pancreat ...... -LSL-Trp53R172H-Pdx1-Cre mice.
@en
P2093
P2860
P356
P1476
Atorvastatin inhibits pancreat ...... -LSL-Trp53R172H-Pdx1-Cre mice.
@en
P2093
Allison L Yang
Guang-Yu Yang
Meng Zhang
Wanying Zhang
Yeon T Chung
P2860
P304
P356
10.1002/MC.21916
P577
2012-04-30T00:00:00Z